MedPath

The effect of zinc sulfate on taste and dry mouth in dialysis patients

Phase 3
Conditions
Evaluation of dysgeusia and dry tongue in patients undergoing chronic hemodialysis.
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
XVIII
Registration Number
IRCT20220808055636N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

No active infection
No active cancer
No active heart disease
Age group of 18-70 years
Minimum onset of dialysis is 6 months.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with dysgeusia and dry mouth in chronic hemodialysis patients. Timepoint: Evaluate dry mouth and dysgeusia at the beginning of the study and 8 weeks after taking zinc sulfate tablets. Method of measurement: Dry mouth and dysgeusia questionnaire.
Secondary Outcome Measures
NameTimeMethod
Increased blood zinc levels in patients. Timepoint: Measurement of zinc blood level at the beginning of the study and 8 weeks after the beginning of the study. Method of measurement: Measurement of zinc blood level by blood test.
© Copyright 2025. All Rights Reserved by MedPath